Dr. Wu Skincare Co., Ltd. (TPEX:6523)
Taiwan · Delayed Price · Currency is TWD 117.50
+1.00 (0.86%)
At close: Mar 26, 2026
Dr. Wu Skincare Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,168 | 1,242 | 1,137 | 926.79 | 1,106 | |
Revenue Growth (YoY) | -5.92% | 9.20% | 22.70% | -16.20% | 44.65% |
Cost of Revenue | 362.67 | 363.68 | 323.12 | 268.78 | 411.65 |
Gross Profit | 805.59 | 878.08 | 814.02 | 658.02 | 694.36 |
Selling, General & Admin | 368.92 | 341.04 | 314.88 | 278.22 | 307.89 |
Research & Development | 9.57 | 12.09 | 9.12 | 7.24 | 10.02 |
Operating Expenses | 378.52 | 353.08 | 324.05 | 285.39 | 317.98 |
Operating Income | 427.07 | 525 | 489.98 | 372.63 | 376.38 |
Interest Expense | -1.39 | -0.82 | -0.26 | -0.52 | -0.76 |
Interest & Investment Income | 36.81 | 37.44 | 32.66 | 10.6 | 7.81 |
Currency Exchange Gain (Loss) | - | 32.21 | 2.22 | 44.56 | -6.09 |
Other Non Operating Income (Expenses) | -21.07 | 0.4 | 0.27 | -1.31 | -3.16 |
EBT Excluding Unusual Items | 441.41 | 594.24 | 524.87 | 425.97 | 374.19 |
Gain (Loss) on Sale of Investments | 0.07 | 1.09 | 0.89 | -1.88 | -1.06 |
Gain (Loss) on Sale of Assets | - | - | - | - | -0.14 |
Asset Writedown | - | - | - | - | -0.97 |
Other Unusual Items | - | - | 0.01 | - | - |
Pretax Income | 441.49 | 595.32 | 525.77 | 424.08 | 372.03 |
Income Tax Expense | 91.21 | 119.07 | 101.03 | 84.1 | 75.78 |
Net Income | 350.27 | 476.25 | 424.73 | 339.98 | 296.24 |
Net Income to Common | 350.27 | 476.25 | 424.73 | 339.98 | 296.24 |
Net Income Growth | -26.45% | 12.13% | 24.93% | 14.77% | -55.19% |
Shares Outstanding (Basic) | 45 | 45 | 45 | 45 | 45 |
Shares Outstanding (Diluted) | 45 | 45 | 45 | 45 | 45 |
Shares Change (YoY) | 0.04% | 0.19% | -0.02% | -0.02% | -0.16% |
EPS (Basic) | 7.78 | 10.57 | 9.43 | 7.55 | 6.58 |
EPS (Diluted) | 7.75 | 10.54 | 9.42 | 7.54 | 6.57 |
EPS Growth | -26.47% | 11.89% | 24.93% | 14.76% | -55.09% |
Free Cash Flow | 335.01 | 434.43 | 389.49 | 324.24 | 290.92 |
Free Cash Flow Per Share | 7.41 | 9.62 | 8.64 | 7.19 | 6.45 |
Dividend Per Share | - | 11.000 | 10.000 | 8.000 | 13.220 |
Dividend Growth | - | 10.00% | 25.00% | -39.49% | 230.50% |
Gross Margin | 68.96% | 70.71% | 71.58% | 71.00% | 62.78% |
Operating Margin | 36.56% | 42.28% | 43.09% | 40.21% | 34.03% |
Profit Margin | 29.98% | 38.35% | 37.35% | 36.68% | 26.78% |
Free Cash Flow Margin | 28.68% | 34.98% | 34.25% | 34.98% | 26.30% |
EBITDA | 436.73 | 528.18 | 494.25 | 377.16 | 383.47 |
EBITDA Margin | 37.38% | 42.54% | 43.46% | 40.70% | 34.67% |
D&A For EBITDA | 9.65 | 3.18 | 4.27 | 4.53 | 7.09 |
EBIT | 427.07 | 525 | 489.98 | 372.63 | 376.38 |
EBIT Margin | 36.56% | 42.28% | 43.09% | 40.21% | 34.03% |
Effective Tax Rate | 20.66% | 20.00% | 19.22% | 19.83% | 20.37% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.